News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 811
- Sources here
- 20
- Companies here
- 19
Active search
811 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Robert Half stock draws income investors as yield tops 5%
Robert Half stock is attracting income investors with its 5.67% dividend yield, despite a "Reduce" consensus rating from analysts and a price target below its current trading level. The company has a strong dividend growth track record, and institutional investors are showing continued interest, …
Is Halozyme Therapeutics (HALO) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Halozyme Therapeutics (HALO) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might …
Q3 EPS Estimate for Hallador Energy Decreased by Analyst
Northland Securities has significantly cut its Q3 2026 EPS forecast for Hallador Energy (NASDAQ: HNRG) to a loss of $0.02 per share, down from a previous estimate of $0.29. This revision follows the company's recent earnings report where it missed consensus EPS estimates, reporting …
Haleon plc (NYSE: HLN) prices $2B multi‑tranche bond to target 2027 notes
Haleon plc announced its subsidiary, Haleon Capital LLC, has priced a $2 billion SEC-registered bond offering across three tranches maturing in 2029, 2031, and 2036, with coupons ranging from 4.625% to 5.375%. The company intends to use the net proceeds, along with cash on …
Haleon prices $2B bond, one of UK health's largest debt raises
Haleon, the UK consumer health group, has priced a $2 billion three-tranche bond offering through its subsidiary Haleon US Capital LLC. The offering aims to repurchase outstanding notes due in March 2027 and refinance debt, with the remaining proceeds for general corporate purposes. This …
Haleon prices $2bn bond offering across three tranches By Investing.com
Haleon US Capital LLC, a wholly-owned subsidiary of Haleon plc, has priced a $2 billion bond offering across three tranches, maturing in 2029, 2031, and 2036 with varying coupon rates. The offering is expected to settle on August 21, 2026, and the proceeds, guaranteed …
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call
The Top 5 Analyst Questions From Halozyme Therapeutics's Q2 Earnings Call Halozyme Therapeutics delivered a notably positive second quarter, as evidenced by the strong market reaction and management's attribution of outperformance to surging royalty revenue and a wave of new collaboration agreements. CEO Helen …
Halliburton (HAL) Stock May Be Undervalued Even After A 94% Run
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Halliburton stock has almost doubled investors' money over the past five years, yet the current valuation checks still point to the shares looking inexpensive …
Sharemaestro market context Price below Trend Line 52 weeks +38.0%Halliburton (HAL) Stock May Stay Cheap Despite Nuclear Waste Push
Halliburton's stock has nearly doubled in five years and still appears undervalued across several metrics, despite new ventures in nuclear waste disposal and AI data center support. The company's P/E ratio of 17.3x is significantly lower than the industry average, suggesting it's underpriced relative …
Capital World Investors trims stake to 4.1% in Robert Half Inc. (RHI)
Capital World Investors has filed an amended beneficial ownership report for Robert Half Inc. (RHI), indicating a trimmed stake of 4.1% in the company. The firm beneficially owns 4,188,139 shares out of 102,293,589 shares outstanding, with sole voting and dispositive power over all these …
Halliburton Co. stock underperforms Wednesday when compared to competitors
Shares of Halliburton Co. (HAL) declined by 1.51% on Wednesday, closing at $33.29. This underperformance occurred on a mixed trading day where the S&P 500 Index rose by 0.26% and the Dow Jones Industrial Average fell by 0.04%. The stock's drop ended a two-day …
Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know
Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the morning session after Brent crude failed to break below $80 and rebounded to the mid-$80s, as traders kept a …
Sharemaestro market context Price below Trend Line 52 weeks +38.0%Haleon slides Wednesday, underperforms market
Haleon PLC (HLN) shares dropped 1.51% to £3.60 on Wednesday, underperforming the broader market as the FTSE 100 Index (UKX) also fell by 0.10%. The company's stock closed significantly below its 52-week high of £4.16, which was reached in February.
Wedge Capital Management L L P NC Invests $31.61 Million in Halozyme Therapeutics, Inc. $HALO
Wedge Capital Management L L P NC has invested $31.61 million in Halozyme Therapeutics, Inc., acquiring 403,824 shares. Halozyme Therapeutics, a biopharmaceutical company, reported strong quarterly results with EPS of $2.28 and revenue of $481 million, exceeding analyst expectations. The company maintains a "Moderate …